| Top 50 Most Viewed Posts This Week |
|---|
|
Today This Week Last Week This Month Last Month
|
1. brentie: "Finally, the Leronlimab, Ulocuplumab, (713)  (22) |
| 2. KenChowder: You forgot the antecedent: Are you gonna partner (707) (21) |
| 3. Jake2212: Based on logic and common sense, the stunning (704) (33) |
| 4. Camp2800: When you add up all of the tea leaves you get (703) (10) |
| 5. My69z: May 8th, 2020: There was also an increases (682) (4) |
| 6. Tprovo: https://www.marketbeat.com/stocks/OTCMKTS/CYDY/sh (633) (9) |
| 7. ohm20: So I turned to our " friend" A I for some (623) (9) |
| 8. MJS719: I believe we are waiting for some new evidence (611) (16) |
| 9. Respert24: Your questions simple enough without 5,000 words (600) (27) |
| 10. Riztheinvestor: When the FDA completely lost oversight during (599) (7) |
| 11. chazzledazzle: I feel you. But I’m strong. And a little needy (594) (6) |
| 12. mountaineer: Yes the following is AI generated, but sounds (588) (6) |
| 13. MGK_2: I didn't get any responses, so I put together my (576) (8) |
| 14. brentie: This is from stocktwits. Nothing too exciting (575) (10) |
| 15. My69z: On the website, under Cancer @ bottom " There is (564) (3) |
| 16. Respert24: Exactly. You'd hope everyone involved in trial (564) (13) |
| 17. nelsonsjavaheads: Just RELAX. This is a board that we are on (562) (16) |
| 18. Respert24: I can’t see the business model you’re (562) (21) |
| 19. sean007: Small compared to overall float,...Butt,...burn (555) (3) |
| 20. Riztheinvestor: Something’s go to give alright. (547) (2) |
| 21. MidnightRider: It's obvious I have been struggling with my LL (545) (9) |
| 22. My69z: If mammogram is positive: LL / ICI regiment LL = (534) (3) |
| 23. Shelly2626: GLTA Longs..... I'm extremely LOOOONNNGG....AND (528) (10) |
| 24. My69z: The FDA ..HAS approved LL @ 700mg CRC before (527) (7) |
| 25. My69z: Cytodyn's 12/7/2022 8-k Investor Oncology (526) (9) |
| 26. Rosner: Short Interest Report As of Sat, Aug 3, '13 (523) |
| 27. brentie: Leronlimab Shows Encouraging Survival Data in (523) (10) |
| 28. hoops: In the meantime CYDY is quietly up 12% on the (521) (4) |
| 29. grow: Yes I agree. Not seeing the ESMO CRC poster yet (516) (3) |
| 30. MGK_2: To Any/All who feel like answering: Let's move to (513) (1) |
| 31. sean007: 8K due for final payment of $2 million from (504) (3) |
| 32. Cycl2R: Jake wrote re LL TNBC conclusive trial: In such a (503) (3) |
| 33. Shelly2626: Been here , but in CYDY SINCE 2012...AND EXPECT (499) (5) |
| 34. My69z: Like i said....he was talking 2 someone (498) |
| 35. Mr3Putt: FWIW on July 9 it'll be the one year anniversary (498) (5) |
| 36. Riztheinvestor: If I had to guess, and I’m not guessing, there (497) (17) |
| 37. Jake2212: Respert: And when the FDA stopped LL for critical (496) (12) |
| 38. john1234: Price, Short Interest, Short Squeeze, Borrow (494) |
| 39. HouseofCards: I would expect updates on any or all of those to (494) (4) |
| 40. My69z: "what is big pharma waiting on ??"..... Well, now (491) (4) |
| 41. Mr3Putt: “You’ve got to ask yourself one question; (490) (4) |
| 42. onestepahead: Yes but 99% of available shares to short are (487) (4) |
| 43. My69z: October 07, 2021 CytoDyn Announces Study to (485) (5) |
| 44. ohm20: Short version: if a company licenses the rights (482) (9) |
| 45. Mr3Putt: IIRC by July 2nd of this month. (468) |
| 46. brentie: New Trials Target Brain, Bladder, Ovarian and (467) (7) |
| 47. chazzledazzle: Short term newsmakers are Company poster for (465) (6) |
| 48. Riztheinvestor: This is very interesting. Haven’t read your (462) (8) |
| 49. 2MartiniGi: Inside the Collapse of the F.D.A. How the new (452) (6) |
| 50. KenChowder: Short version: if a company licenses the rights (451) (1) |
